CVM CEL-SCI Corp. Company Short-Term Debt

CEL-SCI (CVM) - corporate logo

The prospects of CEL-SCI Corporation (CVM) depend on FDA approval and the implementation of Multikine therapy in oncology centers. Short-term debt financing confirms the current financial dynamics, where the indicator is maintained at 0.00. Business revenues will be based on the commercial launch of the drug for the treatment of head and neck tumors. Currently, the strategy relies on the verification of clinical test results before the start of mass production.

CEL-SCI Corp (CVM) - Company Short-Term Loans and Borrowings from 07/04/2022 to 10/30/2026

Summary analytical data breakdowns for CEL-SCI Corp. (CVM)

- stock price and consensus target price:
Stock Price CEL-SCI Corp|CVM - Average Forecast Price
- market capitalization data:
Market Value CEL-SCI Corporation|CVM - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Accounting Value per Share CEL-SCI|CVM - Accounting Value of Company|Market Capitalization to Book Value Ratio cel-sci.com|CVM - Cumulative Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio CEL-SCI Corporation|CVM - Long-Term Debt to Capital|Short-Term Debt to Equity CEL-SCI Corp|CVM - Aggregate Debt Obligations|Debts to Book Capitalization CEL-SCI Corporation|CVM - Long-Term Debt|Company Short-Term Debts CEL-SCI|Quick Ratio cel-sci.com
- earnings and valuation multiples indicators:
CVM - Company Net Income
General company analysis:cel-sci.com (CVM)
Flagship merchandise of CEL-SCI Corp

Investors must closely monitor the liquidity of CEL-SCI Corporation (CVM), as implementing costly ESG standards within biopharmaceuticals and waste disposal requires a stable cash flow. Analyzing current debt on loans and borrowings helps identify working capital deficits between quarterly reports, where a reduction in liabilities may signal either increased resilience or a decline in credit confidence in the issuer.

Main competitors

BeiGene - Company Short-Term Debts|Short-Term Debt Halozyme Therapeutics, Inc.|RevMed (RVMD) - Company Short-Term Debt|Ascentage Pharma Corp - Company Short-Term Loans and Borrowings|Company Current Liabilities CGON|URGN: Company Short-Term Loans and Borrowings|Company Short-Term Debts BCAX|Company Current Liabilities Personalis Inc PSNL|Erasca Corp - Company Current Liabilities|Company Short-Term Debts Delcath Corp DCTH|YMAB - Company Short-Term Debt|Company Short-Term Loans and Borrowings AURA (aurabiosciences.com)|CADL: Company Short-Term Debts|Short-Term Debt Accuray Inc (ARAY)|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Company Current Liabilities Actuate Therapeutics Inc (ACTU)|Company Short-Term Debts CTOR|HURA - Short-Term Debt|Company Short-Term Debt Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc - Company Short-Term Debt|WHWK: Company Current Liabilities|Short-Term Indebtedness TScan Therapeutics (TCRX)|championsoncology.com (CSBR) - Company Short-Term Debt|XBIT - Short-Term Debt Volume|OSTX (OS Therapies) - Company Short-Term Debts|Company Current Liabilities Radiopharm Theranostics Ltd (RADX)|Company Short-Term Debts ARTV|Short-Term Debt Volume adlainortye.com|Veru Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings TPST|Xilio - Company Short-Term Debts|Renovaro Inc. (RENB) - Company Current Liabilities|muraloncology.com (MURA) - Company Short-Term Debt|Short-Term Debt Kairos Pharma (KAPA)|Company Short-Term Debt OnKure Therapeutics, Inc.|GDTC: Company Short-Term Loans and Borrowings|Company Short-Term Debt Curis, Inc. (CRIS)|APLM: Current Liabilities|Company Short-Term Debt Tharimmune Corp THAR|Advanced Biomed Inc. (ADVB) - Short-Term Debt|GNPX - Company Short-Term Debt|Company Short-Term Loans and Borrowings CLDI (Calidi Biotherapeutics)|SBFM: Company Short-Term Debts|Xenetic Biosciences, Inc. (XBIO) - Company Short-Term Debts|Company Current Liabilities SLRX|PPBT (Kitov Pharma) - Amount of Current Liabilities|Company Short-Term Debts AONC|Short-Term Debt Volume beigene.com|Company Short-Term Debt Checkpoint Therapeutics, Inc. CKPT|Elevation Oncology Inc. (ELEV) - Short-Term Debt|ICAD - Company Short-Term Debt|IKNA (Ikena Oncology, Inc.) - Company Short-Term Indebtedness|NTBL: Company Short-Term Debts|Company Current Liabilities Viracta Therapeutics, Inc.|Company Current Liabilities MOR|Company Short-Term Debt NAYA|Company Short-Term Debt Ascentage Pharma Group Ltd (AAPGV)